Further refinement of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure using classical test theory and item response theory

被引:4
|
作者
Pattinson, Rachael [1 ]
Trialonis-Suthakharan, Nirohshah [3 ]
Pickles, Tim [2 ]
Austin, Jennifer [4 ]
FitzGerald, Allison [4 ]
Augustin, Matthias [3 ]
Bundy, Christine [1 ]
机构
[1] Cardiff Univ, Sch Healthcare Sci, Cardiff, Wales
[2] Cardiff Univ, Ctr Trials Res, Cardiff, Wales
[3] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Hamburg, Germany
[4] Int Alliance Dermatol Patient Org, Ottawa, ON, Canada
关键词
SYSTEMATIC REVIEWS; COSMIN; MODEL; INSTRUMENT; CRITERIA;
D O I
10.1093/bjd/ljad487
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Existing dermatology-specific Patient-Reported Outcome Measures (PROMs) do not fully capture the substantial physical, psychological and social impact of dermatological conditions on patients' lives and are not recommended for use according to the COSMIN criteria. Most were developed with insufficient patient involvement and relied on classical psychometric methods. We are developing the new Patient-Reported Impact of Dermatological Diseases (PRIDD) measure for use in research and clinical practice in partnership with patients.Objectives To examine the factor structure of PRIDD, determine the definitive selection of items for each subscale, and establish structural validity and internal consistency through classical and modern psychometric methods.Methods Two cross-sectional online surveys were conducted. Adults (>= 18 years) worldwide living with a dermatological condition were recruited through the membership network of the International Alliance of Dermatology Patient Organizations (GlobalSkin). They completed the PRIDD questionnaire and a demographics questionnaire via an online survey. We examined missing data and distribution of scores for each item. The factor structure was assessed using confirmatory and exploratory factor analysis (Survey 1). Internal consistency was examined using Cronbach's alpha. Rasch measurement theory analyses were conducted, including iterative assessment of rating scale function, fit to the Rasch model, unidimensionality, reliability, local dependence, targeting and differential item functioning (DIF) (Surveys 1 and 2).Results Participants in Surveys 1 and 2 numbered 483 and 504 people, respectively. All items had <= 3% missing scores and all five response options were used. A four-factor model showed the best fit. PRIDD and all four subscales were internally consistent but showed some misfit to the Rasch measurement model. Adjustments were made to rectify disordered thresholds, remove misfitting items, local dependency and DIF, and improve targeting. The resulting 16-item version and subscales fit the Rasch model, showed no local dependency or DIF at the test level, and were well targeted.Conclusions This field test study produced the final PRIDD measure, consisting of 16 items across four domains. The data triangulated and refined the conceptual framework of impact and provide evidence of PRIDD's structural validity and internal consistency. The final step in the development and validation of the PRIDD measure is to test the remaining measurement properties. This study examined the factor structure of the new Patient-Reported Impact of Dermatological Diseases (PRIDD) measure, determined the definitive selection of items for each subscale, and established PRIDD's structural validity and internal consistency through classical and modern psychometric methods. The study produced the final PRIDD tool consisting of 16 items across four domains and provided evidence of the measure's structural validity and internal consistency.
引用
收藏
页码:718 / 728
页数:11
相关论文
共 50 条
  • [1] DEVELOPMENT OF THE PATIENT-REPORTED IMPACT OF DERMATOLOGICAL DISEASES (PRIDD) MEASURE
    Pattinson, R.
    Trialonis-Suthakharan, N.
    Austin, J.
    Augustin, M.
    Bundy, C.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S232 - S232
  • [2] Bridging the gap: validating the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure
    Zhang, Junfen
    Yang, Bin
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024,
  • [3] Measurement properties and interpretability of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure
    Pattinson, Rachael
    Trialonis-Suthakharan, Nirohshah
    Pickles, Tim
    Austin, Jennifer
    Fitzgerald, Allison
    Augustin, Matthias
    Bundy, Christine
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024,
  • [4] Patient-Reported Impact of Dermatological Diseases (PRIDD) is a new patient-reported outcome measure for dermatology: why is it needed?
    Howells, Laura
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (02) : e4 - e4
  • [5] PATIENT-CENTRED DEVELOPMENT AND VALIDATION OF THE PATIENT-REPORTED IMPACT OF DERMATOLOGICAL DISEASES (PRIDD) MEASURE
    Pattinson, Rachael
    Trialonis-Suthakharan, Nirohshah
    Austin, Jennifer
    FitzGerald, Allison
    Augustin, Matthias
    Bundy, Chris
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 10 - 10
  • [6] PATIENT-CENTRED DEVELOPMENT AND VALIDATION OF THE PATIENT-REPORTED IMPACT OF DERMATOLOGICAL DISEASES (PRIDD) MEASURE
    Pattinson, Rachael
    Trialonis-Suthakharan, Nirohshah
    Austin, Jennifer
    FitzGerald, Allison
    Augustin, Matthias
    Bundy, Chris
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 10 - 10
  • [7] Patient-reported impact of dermatological diseases (PRIDD) measure: Pemphigus and pemphigoid delphi data
    Trialonis-Suthakharan, N.
    Pattinson, R.
    Austin, J.
    FitzGerald, A.
    Yale, M.
    Bundy, C.
    Augustin, M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S115 - S115
  • [8] PATIENT-CENTRED DEVELOPMENT AND VALIDATION OF THE PATIENT-REPORTED IMPACT OF DERMATOLOGICAL DISEASES (PRIDD) MEASURE
    Pattinson, Rachael
    Trialonis-Suthakharan, Nirohshah
    Austin, Jennifer
    FitzGerald, Allison
    Augustin, Matthias
    Bundy, Chris
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 10 - 10
  • [9] PATIENT PRIORITISATION OF ITEMS FOR THE NEW PATIENT-REPORTED IMPACT OF DERMATOLOGICAL DISEASES (PRIDD) MEASURE: A DELPHI STUDY
    Pattinson, R.
    Trialonis-Suthakharan, N.
    Gandomkari, Tahmasebi N.
    Lopez, Valencia M. J.
    Austin, J.
    Augustin, M.
    Bundy, C.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S288 - S288
  • [10] Entwicklung des Messinstruments "Patient-Reported Impact of Dermatological Diseases (PRIDD)"
    Trialonis-Suthakharan, Nirohshah
    Pattinson, Rachael
    Austin, Jennifer
    FitzGerald, Allison
    Bundy, Chris
    Augustin, Matthias
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 42 - 42